Results 141 to 150 of about 45,473 (217)

PBP4-mediated β-lactam resistance among clinical strains of Staphylococcus aureus. [PDF]

J Antimicrob Chemother, 2021
Satishkumar N, Alexander JAN, Poon R, Buggeln E, Argudín MA, Strynadka NCJ, Chatterjee SS.   +6 more
europepmc   +1 more source

The Development and Validation of a Simple Method for the Determination of Meropenem Concentrations in Human Plasma Using High‐Performance Liquid Chromatography

Applied Research, Volume 5, Issue 4, August 2026.
A simple, rapid, and sustainable HPLC‐UV method was developed and validated to quantify meropenem in human plasma across a wide linear range (0.5–100 mg/L). Utilizing an efficient one‐step protein precipitation, this eco‐friendly approach is highly suited for routine clinical therapeutic drug monitoring and research purposes.
Asma Aboelezz, Maged Kharouba, Sherif Hanafy Mahmoud   +2 more
wiley   +1 more source

Fecal carriage, transferable β-lactam resistance, and efflux pump contribution in third-generation cephalosporin-resistant <i>Escherichia coli</i> from small-scale farm animals and workers in northern Thailand. [PDF]

Vet World
Tansawai U, Niumsup PR.
europepmc   +1 more source

Usefulness of EUCAST rapid antibiotic susceptibility breakpoints and screening cut-off values directly from blood cultures for the inference of β-lactam resistance mechanisms in Enterobacterales. [PDF]

JAC Antimicrob Resist, 2023
Cerrudo V, Cortés-Cuevas JL, García-Fernández S, Morosini MI, Cantón R, Sánchez-Díaz AM.   +5 more
europepmc   +1 more source

Exploring the Roles of Tuna‐Associated Acinetobacter sp. YFT067: Implications for Host Health and Metabolism

Animal Research and One Health, Volume 4, Issue 3, Page 278-292, August 2026.
This study firstly isolated a tuna‐derived gut probiotic Acinetobacter seifertii YFT067. Dietary administration of YFT067 played significant roles in promoting growth performance, SCFAs production, lipid absorption, and metabolism of the host, indicating YFT067 as a promising probiotic candidate for enhancing tuna aquaculture productivity through ...
Ying Zou, Hai Huang, Qiongyao Fu, Zhiyuan Lu, Zhiqiang Guo   +4 more
wiley   +1 more source

Evolutionary trajectories of β-lactam resistance in <i>Enterococcus faecalis</i> strains. [PDF]

mBio
Ugalde Silva P, Desbonnet C, Rice LB, García-Solache M.   +3 more
europepmc   +1 more source

β-Lactam Resistance in Upper Respiratory Tract Pathogens Isolated from a Tertiary Hospital in Malaysia. [PDF]

Pathogens, 2021
Ngoi ST, Muhamad AN, Teh CSJ, Chong CW, Abdul Jabar K, Chai LC, Leong KC, Tee LH, AbuBakar S.   +8 more
europepmc   +1 more source

Evaluation of a Product Intended for Microbiological Control in Animal Production, and Its Combination With Halquinol

Animal Research and One Health, Volume 4, Issue 3, Page 302-313, August 2026.
Activo Liquid and Halquinol inhibit Salmonella and Escherichia coli in culture media. Activo Liquid exhibits bactericidal action, whereas HA is bacteriostatic, and their combination results in positive or indifferent interactions. This combination effectively inhibits E. coli throughout digestion simulation, thus reducing the required concentrations of
Alberto Gonçalves Evangelista, Lucas dos Santos Janotto, Adriana Paula Possamai, Carolina Cini Perry, Francine Lemes Ribeiro, Rafael Canonenco de Araujo, Fernando Bittencourt Luciano   +6 more
wiley   +1 more source

Choice of β-Lactam Resistance Pathway Depends Critically on Initial Antibiotic Concentration. [PDF]

Antimicrob Agents Chemother, 2021
Ruelens P, de Visser JAGM.
europepmc   +1 more source

Successful Rapid Desensitization to Ceftazidime/Avibactam in a Patient With Cystic Fibrosis and Multidrug‐Resistant Pseudomonas aeruginosa Pneumonia: A Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Ceftazidime/avibactam (CAZ‐AVI) is an important therapeutic option for multidrug‐resistant (MDR) Pseudomonas aeruginosa infections; however, hypersensitivity reactions may preclude its use and create significant therapeutic challenges. We report a 21‐year‐old woman with cystic fibrosis and recurrent MDR P.
Zuoren Zhou, Jinqi Zhu, Ge Wu, Xi Kang, Qing Wang, Jie Liu, Yan Jiang   +6 more
wiley   +1 more source